Conversely, treating mice with an antagonist of the secretion of PRL (bromocriptine) decreased the absolute number of these cells with respect to mice treated with PBS or without treatment; this behavior was only observed in lupus-prone mice. This evidence concerns the gene PRL and systemic lupus erythematosus.